Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit | The Permanente Journal
Peter Kaiser - Client Innovation Centers CFO, Europe, MEA, NA - IBM | LinkedIn